StockData
ImmuCell Corp logo

ImmuCell Corp (ICCC) bonds

ICCCNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/303% above fair value
$11.33−0.09 (-0.79%)

Close on Nov 17, 2026Market cap $102.90MP/E 141.6Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt
$8.30M
$1.51M due within a year
Net debt
-$557.32K
After $8.86M of cash
Implied interest rate
5.02%
FY2025 interest ÷ average debt
Interest coverage
3.3×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

Notes and loans outstanding

As tagged in ImmuCell's 10-Q for the period ended Jun 30, 2026

IssueCouponAmount issuedCarrying value
Debt Instrument Debt Financing Eight6.50%$2.33M–
Debt Instrument Debt Financing Loans One Through Eight––$8.34M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySize
Line Of Credit$1.00M

See a number that looks wrong?